Banco de Crédito e Inversiones Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Banco de Crédito e Inversiones şirketinin toplam varlıkları CLP78,812.2B ve toplam özkaynağı CLP6,619.1B dır. Toplam mevduat CLP42,642.0B ve toplam krediler CLP50,479.4B dır.

Anahtar bilgiler

11.9x

Varlık/özkaynak oranı

n/a

Net faiz marjı

Toplam mevduat	CL$42.64t
Kredi/mevduat oranı	Uygun
Batık krediler	8.0%
Sorunlu krediler için ayrılan karşılık	Düşük
Cari oran	Düşük
Nakit ve eşdeğerleri	CL$12.37t

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Banco de Crédito e Inversiones' (SNSE:BCI) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 28

Is Now The Time To Put Banco de Crédito e Inversiones (SNSE:BCI) On Your Watchlist?

Jul 11

If EPS Growth Is Important To You, Banco de Crédito e Inversiones (SNSE:BCI) Presents An Opportunity

Mar 01

Do Banco de Crédito e Inversiones's (SNSE:BCI) Earnings Warrant Your Attention?

Jun 07

Do Banco de Crédito e Inversiones's (SNSE:BCI) Earnings Warrant Your Attention?

Dec 15

Should Banco de Crédito e Inversiones (SNSE:BCI) Be Part Of Your Dividend Portfolio?

Mar 15

What Type Of Shareholders Own The Most Number of Banco de Crédito e Inversiones (SNSE:BCI) Shares?

Feb 08

What Type Of Returns Would Banco de Crédito e Inversiones'(SNSE:BCI) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 03

Is Banco de Crédito e Inversiones (SNSE:BCI) The Right Choice For A Smart Dividend Investor?

Nov 29

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: BCI 'nin Varlıkların Öz Sermayeye Oranı ( 11.9 x) orta'dır.

Kötü Krediler İçin Ödenek: BCI düşük kötü krediler için ödeneke sahiptir ( 21 %).

Düşük Riskli Yükümlülükler: BCI 'un yükümlülüklerinin 59% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: BCI Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 64% ).

Düşük Riskli Mevduatlar: BCI 'nin Kredi/Mevduat oranı ( 118% ) uygundur.

Kötü Kredilerin Seviyesi: BCI yüksek düzeyde kötü kredi içeriyor ( 8 %).

Banco de Crédito e Inversiones Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Consensus EPS estimates increase by 40%

Third quarter 2024 earnings released: EPS: CL$963 (vs CL$1,094 in 3Q 2023)

Consensus EPS estimates fall by 10%

Consensus EPS estimates increase by 42%

Second quarter 2024 earnings released

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Banco de Crédito e Inversiones to Report Fiscal Year 2024 Results on Feb 28, 2025

First quarter 2024 earnings released: EPS: CL$949 (vs CL$897 in 1Q 2023)

Banco de Crédito e Inversiones, Annual General Meeting, Apr 09, 2024

Banco de Crédito e Inversiones' (SNSE:BCI) Shareholders Will Receive A Smaller Dividend Than Last Year

Dividend of CL$1,000 announced

Full year 2023 earnings released: EPS: CL$3,639 (vs CL$4,634 in FY 2022)

Now 20% undervalued

Banco de Crédito e Inversiones to Report Q1, 2024 Results on Apr 30, 2024

Price target increased by 7.4% to CL$29,014

Full year 2023 earnings released: EPS: CL$3,580 (vs CL$4,634 in FY 2022)

Third quarter 2023 earnings released: EPS: CL$678 (vs CL$994 in 3Q 2022)

Consensus EPS estimates fall by 12%

Consensus EPS estimates increase by 12%, revenue downgraded

New major risk - Earnings quality

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Is Now The Time To Put Banco de Crédito e Inversiones (SNSE:BCI) On Your Watchlist?

First quarter 2023 earnings released: EPS: CL$1,012 (vs CL$1,229 in 1Q 2022)

If EPS Growth Is Important To You, Banco de Crédito e Inversiones (SNSE:BCI) Presents An Opportunity

Banco de Crédito e Inversiones to Report Q3, 2023 Results on Oct 31, 2023

Now 21% undervalued after recent price drop

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CL$1,122 (vs CL$699 in 3Q 2021)

Banco de Crédito e Inversiones to Report Q2, 2022 Results on Sep 15, 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued

Do Banco de Crédito e Inversiones's (SNSE:BCI) Earnings Warrant Your Attention?

Banco de Crédito e Inversiones to Report Q3, 2022 Results on Nov 30, 2022

Less than half of directors are independent

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of CL$1,010 per share

Banco de Crédito e Inversiones to Report Q2, 2022 Final Results on Aug 15, 2022

Consensus EPS estimates increase by 11%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Do Banco de Crédito e Inversiones's (SNSE:BCI) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Consensus EPS estimates increase to CL$3,436

EVO Payments, Inc. (NasdaqGM:EVOP) along with Banco de Crédito e Inversiones (SNSE:BCI) entered into an agreement to acquire Pago Fácil SPA.

Should Banco de Crédito e Inversiones (SNSE:BCI) Be Part Of Your Dividend Portfolio?

New 90-day high: CL$33,990

What Type Of Shareholders Own The Most Number of Banco de Crédito e Inversiones (SNSE:BCI) Shares?

Price target raised to CL$33,977

Banco de Crédito e Inversiones to Report Q4, 2020 Results on Jan 29, 2021

New 90-day high: CL$28,850

What Type Of Returns Would Banco de Crédito e Inversiones'(SNSE:BCI) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

New 90-day high: CL$28,070

Is Banco de Crédito e Inversiones (SNSE:BCI) The Right Choice For A Smart Dividend Investor?

New 90-day high: CL$27,400

New 90-day high: CL$27,000

EVO Payments and Banco de Crédito e Inversiones to Establish New Card Acceptance Joint Venture in Chile

New 90-day low - CL$24,030

New 90-day low - CL$24,970

First half earnings released

Banco de Crédito e Inversiones to Report Q1, 2020 Results on Apr 30, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Sağlıklı şirketleri keşfedin